Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices.

Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint in Europe.

Read full article from Mass Device here. 

We wanted to show you how database release automation fits into the application toolchain. The best part is that it fits in nicely with tools you're probably already using. #DevOps
https://t.co/IoZtrHwfdL

Learn how to reduce the risks & expenses associated with migrating to the #HPC #Cloud from a panel of experts from @Univa_Corp, @AWSCloud & @WekaIO at our Breakfast Briefing at #ISC19 in June. The event is FREE to attend & sponsored by #AWS! Register today https://t.co/j8ObTrdmJs

Thanks to @gemmacorrell for another excellent comic.

#mentalhealth #cpmh
https://t.co/CSiLF7w0k9
https://t.co/PJIqNwIe1S